RNY4
gene geneOn this page
Also known as hY4
Summary
RNY4 (RNA, Ro60-associated Y4, HGNC:10244) is a non-coding RNA gene on chromosome 7q36.1.
At a glance
- Gene type: non-coding (misc_RNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10244 |
| Approved symbol | RNY4 |
| Name | RNA, Ro60-associated Y4 |
| Location | 7q36.1 |
| Locus type | RNA, Y |
| Status | Approved |
| Aliases | hY4 |
| Ensembl gene | ENSG00000252316 |
| Ensembl biotype | misc_RNA |
| OMIM | 601823 |
| Entrez | 6086 |
| RNAcentral | URS0000007D24 — ncRNA, 96 nt, 32 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 misc_RNA
ENST00000516507
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000516507 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002088784 | 148963315 | 148963410 |
Expression profiles
Bgee: expression breadth ubiquitous, 114 present calls, max score 99.76.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 99.76 | gold quality |
| sural nerve | UBERON:0015488 | 99.59 | gold quality |
| corpus callosum | UBERON:0002336 | 94.79 | gold quality |
| granulocyte | CL:0000094 | 92.15 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.15 | gold quality |
| endometrium | UBERON:0001295 | 90.30 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.21 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 88.46 | gold quality |
| monocyte | CL:0000576 | 87.08 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 85.76 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.83 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 83.34 | gold quality |
| liver | UBERON:0002107 | 83.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.79 | gold quality |
| blood | UBERON:0000178 | 82.51 | gold quality |
| stomach | UBERON:0000945 | 82.06 | gold quality |
| kidney | UBERON:0002113 | 81.61 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.57 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 81.29 | gold quality |
| muscle of leg | UBERON:0001383 | 81.24 | gold quality |
| vermiform appendix | UBERON:0001154 | 81.01 | gold quality |
| bone marrow | UBERON:0002371 | 80.28 | gold quality |
| body of stomach | UBERON:0001161 | 80.19 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.04 | gold quality |
| islet of Langerhans | UBERON:0000006 | 79.52 | gold quality |
| right frontal lobe | UBERON:0002810 | 79.42 | gold quality |
| frontal cortex | UBERON:0001870 | 79.35 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 78.98 | gold quality |
| cerebral cortex | UBERON:0000956 | 78.81 | gold quality |
| small intestine | UBERON:0002108 | 78.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.95 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- low expression of RNY1, RNY3 and RNY4 was associated with muscle-invasive BCA, lymph node metastases and advanced grade. Furthermore, expression of RNY1 and RNY3 was predictive for BCA patients’ overall (also RNY4) and cancer-specific survival as estimated using Kaplan-Meier and univariate (but not multivariate) Cox regression analyses. (PMID:29126388)
- yRNA3 up-regulation in cultured dermal fibroblasts and yRNA4 down-regulation in the sera of scleroderma patients. (PMID:33516635)
Cross-species orthologs
0 orthologs
Paralogs (813): Y_RNA (ENSG00000195401), Y_RNA (ENSG00000199200), Y_RNA (ENSG00000199201), Y_RNA (ENSG00000199203), Y_RNA (ENSG00000199204), Y_RNA (ENSG00000199220), Y_RNA (ENSG00000199222), Y_RNA (ENSG00000199223), Y_RNA (ENSG00000199224), Y_RNA (ENSG00000199241), Y_RNA (ENSG00000199245), Y_RNA (ENSG00000199263), Y_RNA (ENSG00000199273), Y_RNA (ENSG00000199285), Y_RNA (ENSG00000199290), Y_RNA (ENSG00000199291), Y_RNA (ENSG00000199303), Y_RNA (ENSG00000199331), Y_RNA (ENSG00000199332), Y_RNA (ENSG00000199349), Y_RNA (ENSG00000199357), Y_RNA (ENSG00000199362), Y_RNA (ENSG00000199366), Y_RNA (ENSG00000199378), Y_RNA (ENSG00000199398), RNY4P19 (ENSG00000199400), Y_RNA (ENSG00000199409), Y_RNA (ENSG00000199410), Y_RNA (ENSG00000199424), Y_RNA (ENSG00000199440), Y_RNA (ENSG00000199442), Y_RNA (ENSG00000199444), Y_RNA (ENSG00000199459), Y_RNA (ENSG00000199461), Y_RNA (ENSG00000199466), Y_RNA (ENSG00000199471), Y_RNA (ENSG00000199472), Y_RNA (ENSG00000199476), Y_RNA (ENSG00000199487), Y_RNA (ENSG00000199490)
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.